These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38605534)

  • 1. Musculoskeletal and cardiovascular considerations for transgender athletes.
    Yang KJ; Kerr C; Rumps MV; Mulcahey M
    Phys Sportsmed; 2024 Apr; ():1-7. PubMed ID: 38605534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Musculoskeletal health considerations for the transgender athlete.
    Birnbaum A; Karamitopoulos M; Carter CW
    Phys Sportsmed; 2023 Oct; 51(5):387-393. PubMed ID: 35373697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A Review.
    Arrington-Sanders R; Connell NT; Coon D; Dowshen N; Goldman AL; Goldstein Z; Grimstad F; Javier NM; Kim E; Murphy M; Poteat T; Radix A; Schwartz A; St Amand C; Streed CG; Tangpricha V; Toribio M; Goldstein RH
    Endocr Pract; 2023 Apr; 29(4):272-278. PubMed ID: 36539066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations for the care of transgender patients in orthopaedics and sports medicine: a narrative review.
    Hayes-Lattin M; Krivicich LM; Bragg JT; Rogerson A; Salzler MJ
    Br J Sports Med; 2024 Jul; ():. PubMed ID: 38997148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy.
    Dix C; Moloney M; Tran HA; McFadyen JD
    Thromb Haemost; 2024 May; 124(5):387-398. PubMed ID: 37816389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M; Jung EE; Bresee C; Garcia MM
    J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study.
    Suppakitjanusant P; Ji Y; Stevenson MO; Chantrapanichkul P; Sineath RC; Goodman M; Alvarez JA; Tangpricha V
    J Clin Transl Endocrinol; 2020 Sep; 21():100230. PubMed ID: 32685379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-affirming pharmacotherapy and additional health considerations: A contemporary review.
    Mercer J; Bandy S; Tang H; Wenger B; Ryan L; Lee G; Lipscomb J
    J Am Pharm Assoc (2003); 2023; 63(6):1669-1676.e1. PubMed ID: 37619851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.
    Wolfe HL; Boyer TL; Shipherd JC; Kauth MR; Jasuja GK; Blosnich JR
    Ann Behav Med; 2023 Nov; 57(12):1014-1023. PubMed ID: 37436725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
    Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
    Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Proposed Inventory to Assess Changes in Orgasm Function of Transgender Patients Following Gender Affirming Treatments: Pilot Study.
    Zaliznyak M; Lauzon M; Stelmar J; Yuan N; Smith SM; Garcia MM
    Sex Med; 2022 Jun; 10(3):100510. PubMed ID: 35472753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-affirming hormone therapy and cardiovascular health in transgender adults.
    Ong C; Monita M; Liu M
    Climacteric; 2024 Jun; 27(3):227-235. PubMed ID: 38597210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
    Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
    J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-Based Gender-Affirming Hormone Therapy and Subclinical Cardiovascular Disease in Transgender Women with HIV.
    Martinez CA; Rikhi R; Fonseca Nogueira N; Pester MS; Salazar AS; Ashinne B; Aguilar N; Melara A; Porras V; Parker M; Mendez A; Cyrus E; De Santis JP; Jones DL; Brown TT; Hurwitz BE; Alcaide ML
    LGBT Health; 2023; 10(8):576-585. PubMed ID: 37459150
    [No Abstract]   [Full Text] [Related]  

  • 17. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
    Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
    Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Utility of Preclinical Models in Understanding the Bone Health of Transgender Individuals Undergoing Gender-Affirming Hormone Therapy.
    Venkatesh VS; Nie T; Zajac JD; Grossmann M; Davey RA
    Curr Osteoporos Rep; 2023 Dec; 21(6):825-841. PubMed ID: 37707757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgender healthcare: metabolic outcomes and cardiovascular risk.
    Glintborg D; Christensen LL; Andersen MS
    Diabetologia; 2024 Jul; ():. PubMed ID: 38958699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgender health and the impact of aging and menopause.
    Cheung AS; Nolan BJ; Zwickl S
    Climacteric; 2023 Jun; 26(3):256-262. PubMed ID: 37011669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.